SANJIVANI PARANTERAL
Back to All Ratios
|
SANJIVANI PARANTERAL Last 5 Year Core EBITDA Growth History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Core EBITDA Growth(%) | 32.06 | - |
What is the latest Core EBITDA Growth ratio of SANJIVANI PARANTERAL ?
| Year | Core EBITDA Growth |
|---|---|
| Mar2025 | 32.06 |
| Mar2024 | - |
How is Core EBITDA Growth of SANJIVANI PARANTERAL Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2025 | 32.06 | 0 | |
| Mar2024 | 0 | - | |
Other Financial Ratios of SANJIVANI PARANTERAL
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹212.0 Cr | -2.4% | -4.7% | -21.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | -2.4% |
-4.7% |
-21.3% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses